Skip to content

Author

S. Malakho

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Biosimilar of the monoclonal antibody immunoglobulin G1κ daratumumab in treatment regimens for multiple myeloma patients

Objeсtive : To evaluate the direct medical costs of treating multiple myeloma (MM) patients with daratumumab and its Russian biosimilar using subcutaneous (SC) and intravenous (IV) administration routes, while considering the patients’ body weights. Material and methods. The targeted patient population...

M. Pankrashkina, A. L. Neverova, S. Malakho et al. · 0 citations
Open access Sep 2026

Genetic landscape of patients at diagnosis of chronic myeloid leukemia in the chronic phase: association with targeted therapy efficacy

Background. Despite advances in the treatment of chronic myeloid leukemia (CML), the problem of resistance to tyrosine kinase inhibitors (TKIs) remains unresolved. The role of additional gene mutations (besides BCR::ABL1) in resistance development is widely discussed. These mutations may influence the development of th...

O. Vinogradova, A. L. Neverova, A. R. Vekua et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.